| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/17/2001 | WO2001034812A1 A method for producing seeds having altered protein/fatty acid composition |
| 05/17/2001 | WO2001034811A2 Bacillus thuringiensis hybrid toxins |
| 05/17/2001 | WO2001034810A2 Genes essential for microbial proliferation |
| 05/17/2001 | WO2001034809A2 Staphylococcus epidermidis nucleic acids and proteins |
| 05/17/2001 | WO2001034808A2 Method of large-scale production and method of testing of the biological activity of a substance from soybean |
| 05/17/2001 | WO2001034807A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2? |
| 05/17/2001 | WO2001034806A2 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034804A1 Human membrane proteins and polynucleotides encoding the same |
| 05/17/2001 | WO2001034803A2 Crib protein zmse1 |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034798A1 Cloning and characterization of viral iap associated factor (viaf) in several organisms |
| 05/17/2001 | WO2001034797A1 Method of preparing cell fraction containing hemangioblasts |
| 05/17/2001 | WO2001034796A1 Chordin-like homologs |
| 05/17/2001 | WO2001034795A2 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis |
| 05/17/2001 | WO2001034794A1 Casb7434, an antigen over-expressed in colon cancer |
| 05/17/2001 | WO2001034793A1 Method of effecting dna splicing |
| 05/17/2001 | WO2001034792A2 Compositions and methods for the diminution or elimination of various cancers |
| 05/17/2001 | WO2001034791A2 Chemoreceptors in plant parasitic nematodes |
| 05/17/2001 | WO2001034790A1 Method for synthesizing nucleic acid |
| 05/17/2001 | WO2001034789A2 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | WO2001034786A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
| 05/17/2001 | WO2001034785A1 Novel metalloprotease having aggrecanase activity |
| 05/17/2001 | WO2001034784A1 Fungamyl-like alpha-amylase variants |
| 05/17/2001 | WO2001034783A1 Novel human kinase protein and polynucleotides encoding the same |
| 05/17/2001 | WO2001034780A2 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | WO2001034779A2 Human proteins with homology to carboxypeptidases and polynucleotides encoding the same |
| 05/17/2001 | WO2001034778A2 Human atpases and polynucleotides encoding the same |
| 05/17/2001 | WO2001034777A1 Symbiotic bacteria and their uses |
| 05/17/2001 | WO2001034774A2 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034652A1 Antibodies to suberic acid crosslinkers and methods for using the same |
| 05/17/2001 | WO2001034649A2 Compositions and methods for treating autoimmune diseases and transplant rejections |
| 05/17/2001 | WO2001034647A2 Animal collagens and gelatins |
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034634A2 Tumor suppressor molecules and methods of use |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034618A2 Synthesis of 2'-deoxy-l-nucleosides |
| 05/17/2001 | WO2001034302A2 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | WO2001034292A2 Macroporous media for biological application prepared by freeze drying |
| 05/17/2001 | WO2001034207A1 Gene carriers |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034179A1 Method of inducing angiogenesis |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034130A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 05/17/2001 | WO2001034091A2 Modification of polysaccharide containing materials |
| 05/17/2001 | WO2001033957A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 05/17/2001 | WO2001033956A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033955A1 Animal models for cardiac disease |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033945A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | WO2001033944A1 Compositions and methods for modulation of plant cell division |
| 05/17/2001 | WO2001033943A1 A method of plant transformation |
| 05/17/2001 | WO2001023577A3 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 05/17/2001 | WO2001020003A3 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 05/17/2001 | WO2001019861A3 Apo-2 receptor antibodies |
| 05/17/2001 | WO2001019183A3 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 05/17/2001 | WO2001018233A3 Screening for inhibitors of lumazine synthase |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
| 05/17/2001 | WO2001009339A3 Moraxella catarrhalis antigen basb117 |
| 05/17/2001 | WO2001009309A3 RESCUE OF MUMPS VIRUS FROM cDNA |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007602A3 Oligonucleotides for inhibiting the expression of human eg5 |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000075368A3 Method for the synthesis of dna fragments |
| 05/17/2001 | WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism |
| 05/17/2001 | WO2000070044A3 Human brain t calcium channel alpha-subunit splice variants |
| 05/17/2001 | WO2000068414A3 Whole cell assay for cathepsin k |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO2000040613A9 Insulin-like growth factor (igf) i mutant variants |
| 05/17/2001 | WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 05/17/2001 | WO2000030437A9 Transgenic animals |
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO2000016609A9 Novel method of regulating seed development in plants and genetic sequences therefor |
| 05/17/2001 | WO1999058562A3 Novel compounds |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | WO1999038972A9 Human genes and gene expression products ii |
| 05/17/2001 | WO1995002040A3 New stromal cell lines from human bone marrow and their use |